Download PDF
Dtsch Med Wochenschr 2003; 128(34/35): 1792
DOI: 10.1055/s-2003-41704
Fragen aus der Praxis
© Georg Thieme Verlag Stuttgart · New York

L-Carnitin und Lipidsenkung

Further Information

Publication History

Publication Date:
22 August 2003 (online)

Also available at
    Permissions and Reprints

Frage: Welchen Stellenwert hat L-Carnitin in der Therapie zur Lipidsenkung?

Literatur

  • 1 Executive committee of the International Atherosclerosis Society .Harmonized clinical guidelines on prevention of atherosclerotic vascular disease. Houston, TX: International Atherosclerosis Society 2003
    Google Scholar
  • 2 Golper T A, Goral S, Becker B N, Langman C B. L-carnitine treatment of anemia.  Am J Kidney Dis. 2003;  41 S27-34
    Google Scholar
  • 3 Heinonen O J. Carnitine and physical exercise.  Sports Med. 1996;  22 109-132
    Google Scholar
  • 4 Hoppel C. The physiological role of carnitin. London: Academic press In: Ferrari R, DiMauro S, Sherwood G, editors. L-carnitine and its role in medicine 1992: 5-19
    Google Scholar
  • 5 Stanley C A. Disorders of fatty acid oxidation. Berlin, Heidelberg, New York: Spinger In: Fernandes J, Saudubray J-M, van den Berghe G, editors. Inborn metabolic diseases: Diagnosis and treatment 2000: 141-150
    Google Scholar

Autoren

Dr. med. Martin Merkel
Prof. Dr. med. Heiner Greten

Zentrum für Innere Medizin, Medizinische Klinik und Poliklinik I, Universitätsklinikum Hamburg-Eppendorf

Martinistraße 52

20246 Hamburg

      >